Staying Strong and Healthy during Androgen Deprivation Therapy for Latino Men

拉丁裔男性在雄激素剥夺疗法期间保持强壮和健康

基本信息

  • 批准号:
    8931060
  • 负责人:
  • 金额:
    $ 61.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-23 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Androgen deprivation therapy (ADT) is increasingly being used to treat prostate cancer in the neoadjuvant and adjuvant contexts with radiation therapy (RT), for recurrence following primary treatment with surgery or radiation, or when the prostate cancer is at an advanced stage. This becomes highly significant considering that prostate cancer is the most commonly diagnosed no cutaneous cancer in American men. Of particular concern are Latino men, because Latinos are the fastest growing minority in the United States (US). Latino men are diagnosed with later stage disease making them more likely to be treated with ADT. Studies have shown that men on ADT are at increased risk for vasomotor symptoms, depression, fatigue, diminished health- related quality of life (HRQOL), decreased bone mineral density (BMD), sexual dysfunction, metabolic syndrome, increased fat mass, along with decreased lean muscle mass, increased serum lipids, and decreased arterial compliance all of which places them at higher risk for cardiovascular disease (CVD), osteoporosis, and type II diabetes. Latinos more often have obesity, dyslipidemia, low cardiovascular fitness, hypertension, and diabetes. Therefore, we propose to test our Staying Strong and Healthy program to promote healthy activity and nutrition during ADT for Latino men. Using a mixed methods design we aim to: 1. Compare pre- and post-intervention BMI, lipids, waist/hip circumference, and glucose within and between 75 Latino men starting ADT who are randomly assigned to receive the Staying Strong and Healthy intervention and 75 Latino men starting ADT randomly assigned to receive usual care. 2. Compare pre- and post- intervention HRQOL using the SF-12 subscales of emotional and physical well-being and disease-specific HRQOL using the Expanded Prostate Cancer Index Composite (EPIC) within and between groups. 3. Develop and compare explanatory models of Latino men's activity and nutrition choices between those receiving the intervention and those receiving usual care. 4. Evaluate acceptability and benefit of the intervention from perspective of participants. Latino men will be recruited form several sites serving predominantly Latino populations in Los Angeles. Men will come to UCLA Center for Translational Research for baseline, 6 and 12 months measures and interview at 12 months. Men assigned to the intervention group will receive initial assessment and education on nutrition and the exercised program immediately following baseline measures. They will then receive 12 weekly calls from a nurse coordinator/cultural liaison team to deliver focused information, establish individually tailored nutrition and activity goals, assess accomplishments of goals and provide support. We will conduct qualitative interview with 30 men from each group to assess the intervention from their perspective and to develop explanatory frameworks for decision process used relative to food and activity choices. Analysis will combine within and between group comparisons and grounded theory techniques.
描述(由申请人提供):雄激素剥夺疗法(ADT)越来越多地用于治疗新辅助和辅助疗法的前列腺癌(RT),用于手术或放射线的初级治疗后复发,或者在前列腺癌处于晚期治疗。考虑到前列腺癌是美国男性最常见的皮肤癌,这变得非常重要。拉丁美洲人特别关心的是拉丁美洲人,因为拉丁美洲人是美国增长最快的少数群体(美国)。拉丁裔男性被诊断出患有后期疾病,使他们更有可能接受ADT治疗。研究表明,ADT上的男性患血管舒缩症状,抑郁症,疲劳,与健康相关的生活质量降低(HRQOL),骨矿物质密度(BMD)降低(BMD),性功能障碍,代谢综合征,脂肪质量的增加,以及较高的肌肉质量降低,较高的肌肉和较高的疾病,脂肪质量降低了,脂肪质量降低了。 (CVD),骨质疏松症和II型糖尿病。拉丁美洲人经常患有肥胖症,血脂异常,低心血管健身,高血压和糖尿病。因此,我们建议测试我们坚强健康的计划,以促进拉丁裔男性在ADT期间促进健康的活动和营养。使用混合方法设计,我们的目的是:1。比较干预前和干预后的BMI,脂质,腰围/臀部周围和葡萄糖在内外的75名拉丁裔男性中,他们开始随机分配ADT,以随机分配以接受坚强健康的干预,以及75名拉丁裔男性开始随机分配ADT,从而随机分配了接受常规护理。 2。使用情绪和身体健康的SF-12分量表和疾病特异性的HRQOL比较前后的HRQOL,并使用群体内外的前列腺癌指数综合(EPIC)进行比较。 3。开发并比较接受干预措施的人与接受常规护理的人之间的拉丁裔男性活动和营养选择的解释模型。 4。从参与者的角度评估干预的可接受性和利益。拉丁裔男子将被招募,形成几个地点,在洛杉矶主要是拉丁裔人口。男子将来到加州大学洛杉矶分校的基线转化研究中心,6个月和12个月的措施,并在12个月时进行访谈。分配给干预小组的男性将在基线措施后立即接受有关营养的初步评估和营养和行使计划的教育。然后,他们将收到护士协调员/文化联络小组的每周12个电话,以提供专注的信息,建立单独量身定制的营养和活动目标,评估目标成就并提供支持。我们将对来自每个小组的30名男性进行定性访谈,以评估他们的角度的干预措施,并开发相对于食物和活动选择的决策过程的解释性框架。分析将结合组内和之间的比较和接地理论技术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SALLY L Maliski其他文献

SALLY L Maliski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SALLY L Maliski', 18)}}的其他基金

Staying Strong and Healthy during Androgen Deprivation Therapy for Latino Men
拉丁裔男性在雄激素剥夺疗法期间保持强壮和健康
  • 批准号:
    8650129
  • 财政年份:
    2014
  • 资助金额:
    $ 61.98万
  • 项目类别:
Staying Strong and Healthy for Androgen Deprivation Therapy for Latino Men
拉丁裔男性接受雄激素剥夺疗法,保持强壮和健康
  • 批准号:
    9753771
  • 财政年份:
    2014
  • 资助金额:
    $ 61.98万
  • 项目类别:
Staying Strong and Healthy for Androgen Deprivation Therapy for Latino Men
拉丁裔男性接受雄激素剥夺疗法,保持强壮和健康
  • 批准号:
    9319910
  • 财政年份:
    2014
  • 资助金额:
    $ 61.98万
  • 项目类别:
A Mixed Methods Approach to Understand Donor Choice
了解捐助者选择的混合方法
  • 批准号:
    8702950
  • 财政年份:
    2014
  • 资助金额:
    $ 61.98万
  • 项目类别:
Underserved Men's Understanding of Androgen Deprivation Therapy Related Risks
服务不足的男性对雄激素剥夺疗法相关风险的了解
  • 批准号:
    8090192
  • 财政年份:
    2011
  • 资助金额:
    $ 61.98万
  • 项目类别:
Underserved Men's Understanding of Androgen Deprivation Therapy Related Risks
服务不足的男性对雄激素剥夺疗法相关风险的了解
  • 批准号:
    8258702
  • 财政年份:
    2011
  • 资助金额:
    $ 61.98万
  • 项目类别:
Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men
确诊和高危拉丁裔男性的前列腺癌临床决策
  • 批准号:
    7693849
  • 财政年份:
    2008
  • 资助金额:
    $ 61.98万
  • 项目类别:
Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men
确诊和高危拉丁裔男性的前列腺癌临床决策
  • 批准号:
    7531018
  • 财政年份:
    2008
  • 资助金额:
    $ 61.98万
  • 项目类别:
Health Literacy and Self-Efficacy Among Low-Income Men with Prostate Cancer
低收入前列腺癌男性的健康素养和自我效能
  • 批准号:
    7488403
  • 财政年份:
    2007
  • 资助金额:
    $ 61.98万
  • 项目类别:
Health Literacy and Self-Efficacy Among Low-Income Men with Prostate Cancer
低收入前列腺癌男性的健康素养和自我效能
  • 批准号:
    7300952
  • 财政年份:
    2007
  • 资助金额:
    $ 61.98万
  • 项目类别:

相似国自然基金

共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
  • 批准号:
    42202336
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
  • 批准号:
    32270554
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
成就目标视角下建言韧性的形成机制与作用效果研究
  • 批准号:
    72102228
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

An Integrated Data Approach to Exploring Racial Differences in Reading Intervention Effectiveness
探索阅读干预效果中种族差异的综合数据方法
  • 批准号:
    10567796
  • 财政年份:
    2023
  • 资助金额:
    $ 61.98万
  • 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
  • 批准号:
    10569397
  • 财政年份:
    2023
  • 资助金额:
    $ 61.98万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10555893
  • 财政年份:
    2023
  • 资助金额:
    $ 61.98万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10712291
  • 财政年份:
    2023
  • 资助金额:
    $ 61.98万
  • 项目类别:
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease
镰状细胞病儿童静脉血栓栓塞 (VTE) 的临床和分子预后因素
  • 批准号:
    10739524
  • 财政年份:
    2023
  • 资助金额:
    $ 61.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了